Low bioavailability of cyclosporine microemulsion and tacrolimus in a small bowel transplant recipient: possible relationship to intestinal P-glycoprotein activity

Transplantation. 1999 Jan 27;67(2):333-5. doi: 10.1097/00007890-199901270-00026.

Abstract

With intestine transplants the allograft is dependent on itself for maintenance of adequate immunosuppression. We evaluated an intestinal transplant recipient who required very large doses of either tacrolimus or cyclosporine emulsion to achieve acceptable blood concentrations. Pharmacokinetic studies revealed bioavailabilities of 2% and 6% respectively, while D-xylose and B12 absorption were found to be within normal limits and fecal fat was only slightly increased, suggesting that there was a selective absorptive defect for these drugs. Biopsies of the allograft ileum revealed a high P-glycoprotein activity compared to the jejunum or to intestinal biopsies from other normal subjects. This may be a contributing factor to poor immunosuppressive drug absorption in this patient and others.

Publication types

  • Case Reports

MeSH terms

  • Biological Availability
  • Chemistry, Pharmaceutical
  • Cyclosporine / pharmacokinetics*
  • Cyclosporine / therapeutic use
  • Emulsions
  • Female
  • Humans
  • Immunosuppressive Agents / pharmacokinetics*
  • Immunosuppressive Agents / therapeutic use
  • Intestinal Absorption*
  • Intestinal Pseudo-Obstruction / surgery
  • Intestine, Small / physiology
  • Intestine, Small / surgery*
  • Middle Aged
  • Tacrolimus / pharmacokinetics*
  • Tacrolimus / therapeutic use
  • Transplantation, Homologous / immunology
  • Transplantation, Homologous / physiology*

Substances

  • Emulsions
  • Immunosuppressive Agents
  • Cyclosporine
  • Tacrolimus